Renal and Neurologic Benefit of Levosimendan vs Dobutamine in Patients With Low Cardiac Output Syndrome After Cardiac Surgery: Clinical Trial FIM-BGC-2014-01

BACKGROUND: Low-cardiac output syndrome (LCOS) after cardiac surgery secondary to systemic hypoperfusion is associated with a higher incidence of renal and neurological damage. A range of effective therapies are available for LCOS. The beneficial systemic effects of levosimendan persist even after c...

Descripción completa

Detalles Bibliográficos
Autores principales: Guerrero-Orriach, Jose L., Malo-Manso, Alfredo, Ramirez-Aliaga, Marta, Florez Vela, Ana Isabel, Galán-Ortega, Manuel, Moreno-Cortes, Isabel, Gonzalez-Almendros, Inmaculada, Ramirez-Fernandez, Alicia, Ariza-Villanueva, Daniel, Escalona-Belmonte, Juan Jose, Quesada-Muñoz, Guillermo, Sepúlveda-Haro, Enrique, Romero-Molina, Salvador, Bellido-Estevez, Inmaculada, Gomez-Luque, Aurelio, Rubio-Navarro, Manuel, Alcaide-Torres, Juan, Santiago-Fernandez, Concepcion, Garrido-Sanchez, Lourdes, Cruz-Mañas, Jose
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7479222/
https://www.ncbi.nlm.nih.gov/pubmed/32982742
http://dx.doi.org/10.3389/fphar.2020.01331

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7479222/
https://www.ncbi.nlm.nih.gov/pubmed/32982742
http://dx.doi.org/10.3389/fphar.2020.01331

Ejemplares similares